Amittha Wickrema to Prospective Studies
This is a "connection" page, showing publications Amittha Wickrema has written about Prospective Studies.
Connection Strength
0.009
-
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38.
Score: 0.009